Pomalidomide capsules are an oral medication used to treat multiple myeloma. Pomalidomide is an immunomodulatory agent that works by modifying the immune system, inhibiting the growth of these cells, and disrupting their ability to form new blood vessels.

The global Pomalidomide Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Pomalidomide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Pomalidomide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Pomalidomide Capsules include Bristol Myers Squibb, Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Apotex, Dr Reddy’s Laboratories, Natco Pharma, Adalvo, Hetero, Abbott Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pomalidomide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide Capsules.

The Pomalidomide Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pomalidomide Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pomalidomide Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pomalidomide Capsules Market Report

Report Metric	Details
Report Name	Pomalidomide Capsules Market
Segment by Type	1mg per Unit 2mg per Unit 3mg per Unit 4mg per Unit
Segment by Application	Kaposi Sarcoma Multiple Myeloma
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bristol Myers Squibb, Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Apotex, Dr Reddy’s Laboratories, Natco Pharma, Adalvo, Hetero, Abbott Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pomalidomide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pomalidomide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pomalidomide Capsules Market report?

Ans: The main players in the Pomalidomide Capsules Market are Bristol Myers Squibb, Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Apotex, Dr Reddy’s Laboratories, Natco Pharma, Adalvo, Hetero, Abbott Laboratories

What are the Application segmentation covered in the Pomalidomide Capsules Market report?

Ans: The Applications covered in the Pomalidomide Capsules Market report are Kaposi Sarcoma, Multiple Myeloma

What are the Type segmentation covered in the Pomalidomide Capsules Market report?

Ans: The Types covered in the Pomalidomide Capsules Market report are 1mg per Unit, 2mg per Unit, 3mg per Unit, 4mg per Unit

1 Pomalidomide Capsules Market Overview

1.1 Product Definition

1.2 Pomalidomide Capsules by Type

1.2.1 Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030)

1.2.2 1mg per Unit

1.2.3 2mg per Unit

1.2.4 3mg per Unit

1.2.5 4mg per Unit

1.3 Pomalidomide Capsules by Application

1.3.1 Global Pomalidomide Capsules Market Value by Application (2024-2030)

1.3.2 Kaposi Sarcoma

1.3.3 Multiple Myeloma

1.4 Global Pomalidomide Capsules Market Size Estimates and Forecasts

1.4.1 Global Pomalidomide Capsules Revenue 2019-2030

1.4.2 Global Pomalidomide Capsules Sales 2019-2030

1.4.3 Global Pomalidomide Capsules Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pomalidomide Capsules Market Competition by Manufacturers

2.1 Global Pomalidomide Capsules Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pomalidomide Capsules Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pomalidomide Capsules Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Pomalidomide Capsules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pomalidomide Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pomalidomide Capsules, Product Type & Application

2.7 Global Key Manufacturers of Pomalidomide Capsules, Date of Enter into This Industry

2.8 Global Pomalidomide Capsules Market Competitive Situation and Trends

2.8.1 Global Pomalidomide Capsules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pomalidomide Capsules Players Market Share by Revenue

2.8.3 Global Pomalidomide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pomalidomide Capsules Market Scenario by Region

3.1 Global Pomalidomide Capsules Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pomalidomide Capsules Sales by Region: 2019-2030

3.2.1 Global Pomalidomide Capsules Sales by Region: 2019-2024

3.2.2 Global Pomalidomide Capsules Sales by Region: 2025-2030

3.3 Global Pomalidomide Capsules Revenue by Region: 2019-2030

3.3.1 Global Pomalidomide Capsules Revenue by Region: 2019-2024

3.3.2 Global Pomalidomide Capsules Revenue by Region: 2025-2030

3.4 North America Pomalidomide Capsules Market Facts & Figures by Country

3.4.1 North America Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pomalidomide Capsules Sales by Country (2019-2030)

3.4.3 North America Pomalidomide Capsules Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pomalidomide Capsules Market Facts & Figures by Country

3.5.1 Europe Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pomalidomide Capsules Sales by Country (2019-2030)

3.5.3 Europe Pomalidomide Capsules Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pomalidomide Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Pomalidomide Capsules Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pomalidomide Capsules Sales by Region (2019-2030)

3.6.3 Asia Pacific Pomalidomide Capsules Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pomalidomide Capsules Market Facts & Figures by Country

3.7.1 Latin America Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pomalidomide Capsules Sales by Country (2019-2030)

3.7.3 Latin America Pomalidomide Capsules Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pomalidomide Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Pomalidomide Capsules Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pomalidomide Capsules Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pomalidomide Capsules Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pomalidomide Capsules Sales by Type (2019-2030)

4.1.1 Global Pomalidomide Capsules Sales by Type (2019-2024)

4.1.2 Global Pomalidomide Capsules Sales by Type (2025-2030)

4.1.3 Global Pomalidomide Capsules Sales Market Share by Type (2019-2030)

4.2 Global Pomalidomide Capsules Revenue by Type (2019-2030)

4.2.1 Global Pomalidomide Capsules Revenue by Type (2019-2024)

4.2.2 Global Pomalidomide Capsules Revenue by Type (2025-2030)

4.2.3 Global Pomalidomide Capsules Revenue Market Share by Type (2019-2030)

4.3 Global Pomalidomide Capsules Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pomalidomide Capsules Sales by Application (2019-2030)

5.1.1 Global Pomalidomide Capsules Sales by Application (2019-2024)

5.1.2 Global Pomalidomide Capsules Sales by Application (2025-2030)

5.1.3 Global Pomalidomide Capsules Sales Market Share by Application (2019-2030)

5.2 Global Pomalidomide Capsules Revenue by Application (2019-2030)

5.2.1 Global Pomalidomide Capsules Revenue by Application (2019-2024)

5.2.2 Global Pomalidomide Capsules Revenue by Application (2025-2030)

5.2.3 Global Pomalidomide Capsules Revenue Market Share by Application (2019-2030)

5.3 Global Pomalidomide Capsules Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bristol Myers Squibb

6.1.1 Bristol Myers Squibb Company Information

6.1.2 Bristol Myers Squibb Description and Business Overview

6.1.3 Bristol Myers Squibb Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bristol Myers Squibb Pomalidomide Capsules Product Portfolio

6.1.5 Bristol Myers Squibb Recent Developments/Updates

6.2 Chia Tai Tianqing Pharmaceutical

6.2.1 Chia Tai Tianqing Pharmaceutical Company Information

6.2.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.2.3 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio

6.2.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

6.3 Qilu Pharmaceutical

6.3.1 Qilu Pharmaceutical Company Information

6.3.2 Qilu Pharmaceutical Description and Business Overview

6.3.3 Qilu Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio

6.3.5 Qilu Pharmaceutical Recent Developments/Updates

6.4 Apotex

6.4.1 Apotex Company Information

6.4.2 Apotex Description and Business Overview

6.4.3 Apotex Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Apotex Pomalidomide Capsules Product Portfolio

6.4.5 Apotex Recent Developments/Updates

6.5 Dr Reddy’s Laboratories

6.5.1 Dr Reddy’s Laboratories Company Information

6.5.2 Dr Reddy’s Laboratories Description and Business Overview

6.5.3 Dr Reddy’s Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio

6.5.5 Dr Reddy’s Laboratories Recent Developments/Updates

6.6 Natco Pharma

6.6.1 Natco Pharma Company Information

6.6.2 Natco Pharma Description and Business Overview

6.6.3 Natco Pharma Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Natco Pharma Pomalidomide Capsules Product Portfolio

6.6.5 Natco Pharma Recent Developments/Updates

6.7 Adalvo

6.7.1 Adalvo Company Information

6.7.2 Adalvo Description and Business Overview

6.7.3 Adalvo Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Adalvo Pomalidomide Capsules Product Portfolio

6.7.5 Adalvo Recent Developments/Updates

6.8 Hetero

6.8.1 Hetero Company Information

6.8.2 Hetero Description and Business Overview

6.8.3 Hetero Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Hetero Pomalidomide Capsules Product Portfolio

6.8.5 Hetero Recent Developments/Updates

6.9 Abbott Laboratories

6.9.1 Abbott Laboratories Company Information

6.9.2 Abbott Laboratories Description and Business Overview

6.9.3 Abbott Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Abbott Laboratories Pomalidomide Capsules Product Portfolio

6.9.5 Abbott Laboratories Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pomalidomide Capsules Industry Chain Analysis

7.2 Pomalidomide Capsules Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pomalidomide Capsules Production Mode & Process

7.4 Pomalidomide Capsules Sales and Marketing

7.4.1 Pomalidomide Capsules Sales Channels

7.4.2 Pomalidomide Capsules Distributors

7.5 Pomalidomide Capsules Customers

8 Pomalidomide Capsules Market Dynamics

8.1 Pomalidomide Capsules Industry Trends

8.2 Pomalidomide Capsules Market Drivers

8.3 Pomalidomide Capsules Market Challenges

8.4 Pomalidomide Capsules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bristol–Myers Squibb

Chia Tai-Tianqing Pharmaceutical

Qilu Pharmaceutical

Apotex

Dr. Reddy’s Laboratories

List of Tables

Table 1. Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pomalidomide Capsules Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Pomalidomide Capsules Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pomalidomide Capsules Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Pomalidomide Capsules Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pomalidomide Capsules Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pomalidomide Capsules Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pomalidomide Capsules Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pomalidomide Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pomalidomide Capsules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pomalidomide Capsules, Product Type & Application

Table 12. Global Key Manufacturers of Pomalidomide Capsules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pomalidomide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pomalidomide Capsules as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pomalidomide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pomalidomide Capsules Sales by Region (2019-2024) & (K Units)

Table 18. Global Pomalidomide Capsules Sales Market Share by Region (2019-2024)

Table 19. Global Pomalidomide Capsules Sales by Region (2025-2030) & (K Units)

Table 20. Global Pomalidomide Capsules Sales Market Share by Region (2025-2030)

Table 21. Global Pomalidomide Capsules Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pomalidomide Capsules Revenue Market Share by Region (2019-2024)

Table 23. Global Pomalidomide Capsules Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pomalidomide Capsules Revenue Market Share by Region (2025-2030)

Table 25. North America Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)

Table 27. North America Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)

Table 28. North America Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)

Table 32. Europe Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)

Table 33. Europe Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pomalidomide Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pomalidomide Capsules Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Pomalidomide Capsules Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Pomalidomide Capsules Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pomalidomide Capsules Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pomalidomide Capsules Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Pomalidomide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Pomalidomide Capsules Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Pomalidomide Capsules Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Pomalidomide Capsules Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Pomalidomide Capsules Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pomalidomide Capsules Sales (K Units) by Type (2019-2024)

Table 51. Global Pomalidomide Capsules Sales (K Units) by Type (2025-2030)

Table 52. Global Pomalidomide Capsules Sales Market Share by Type (2019-2024)

Table 53. Global Pomalidomide Capsules Sales Market Share by Type (2025-2030)

Table 54. Global Pomalidomide Capsules Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pomalidomide Capsules Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pomalidomide Capsules Revenue Market Share by Type (2019-2024)

Table 57. Global Pomalidomide Capsules Revenue Market Share by Type (2025-2030)

Table 58. Global Pomalidomide Capsules Price (US$/Unit) by Type (2019-2024)

Table 59. Global Pomalidomide Capsules Price (US$/Unit) by Type (2025-2030)

Table 60. Global Pomalidomide Capsules Sales (K Units) by Application (2019-2024)

Table 61. Global Pomalidomide Capsules Sales (K Units) by Application (2025-2030)

Table 62. Global Pomalidomide Capsules Sales Market Share by Application (2019-2024)

Table 63. Global Pomalidomide Capsules Sales Market Share by Application (2025-2030)

Table 64. Global Pomalidomide Capsules Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pomalidomide Capsules Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pomalidomide Capsules Revenue Market Share by Application (2019-2024)

Table 67. Global Pomalidomide Capsules Revenue Market Share by Application (2025-2030)

Table 68. Global Pomalidomide Capsules Price (US$/Unit) by Application (2019-2024)

Table 69. Global Pomalidomide Capsules Price (US$/Unit) by Application (2025-2030)

Table 70. Bristol Myers Squibb Company Information

Table 71. Bristol Myers Squibb Description and Business Overview

Table 72. Bristol Myers Squibb Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Bristol Myers Squibb Pomalidomide Capsules Product

Table 74. Bristol Myers Squibb Recent Developments/Updates

Table 75. Chia Tai Tianqing Pharmaceutical Company Information

Table 76. Chia Tai Tianqing Pharmaceutical Description and Business Overview

Table 77. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product

Table 79. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

Table 80. Qilu Pharmaceutical Company Information

Table 81. Qilu Pharmaceutical Description and Business Overview

Table 82. Qilu Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Qilu Pharmaceutical Pomalidomide Capsules Product

Table 84. Qilu Pharmaceutical Recent Developments/Updates

Table 85. Apotex Company Information

Table 86. Apotex Description and Business Overview

Table 87. Apotex Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Apotex Pomalidomide Capsules Product

Table 89. Apotex Recent Developments/Updates

Table 90. Dr Reddy’s Laboratories Company Information

Table 91. Dr Reddy’s Laboratories Description and Business Overview

Table 92. Dr Reddy’s Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Dr Reddy’s Laboratories Pomalidomide Capsules Product

Table 94. Dr Reddy’s Laboratories Recent Developments/Updates

Table 95. Natco Pharma Company Information

Table 96. Natco Pharma Description and Business Overview

Table 97. Natco Pharma Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Natco Pharma Pomalidomide Capsules Product

Table 99. Natco Pharma Recent Developments/Updates

Table 100. Adalvo Company Information

Table 101. Adalvo Description and Business Overview

Table 102. Adalvo Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Adalvo Pomalidomide Capsules Product

Table 104. Adalvo Recent Developments/Updates

Table 105. Hetero Company Information

Table 106. Hetero Description and Business Overview

Table 107. Hetero Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Hetero Pomalidomide Capsules Product

Table 109. Hetero Recent Developments/Updates

Table 110. Abbott Laboratories Company Information

Table 111. Abbott Laboratories Description and Business Overview

Table 112. Abbott Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Abbott Laboratories Pomalidomide Capsules Product

Table 114. Abbott Laboratories Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Pomalidomide Capsules Distributors List

Table 118. Pomalidomide Capsules Customers List

Table 119. Pomalidomide Capsules Market Trends

Table 120. Pomalidomide Capsules Market Drivers

Table 121. Pomalidomide Capsules Market Challenges

Table 122. Pomalidomide Capsules Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pomalidomide Capsules

Figure 2. Global Pomalidomide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pomalidomide Capsules Market Share by Type: 2023 & 2030

Figure 4. 1mg per Unit Product Picture

Figure 5. 2mg per Unit Product Picture

Figure 6. 3mg per Unit Product Picture

Figure 7. 4mg per Unit Product Picture

Figure 8. Global Pomalidomide Capsules Market Value by Application (2024-2030) & (US$ Million)

Figure 9. Global Pomalidomide Capsules Market Share by Application: 2023 & 2030

Figure 10. Kaposi Sarcoma

Figure 11. Multiple Myeloma

Figure 12. Global Pomalidomide Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pomalidomide Capsules Market Size (2019-2030) & (US$ Million)

Figure 14. Global Pomalidomide Capsules Sales (2019-2030) & (K Units)

Figure 15. Global Pomalidomide Capsules Average Price (US$/Unit) & (2019-2030)

Figure 16. Pomalidomide Capsules Report Years Considered

Figure 17. Pomalidomide Capsules Sales Share by Manufacturers in 2023

Figure 18. Global Pomalidomide Capsules Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Pomalidomide Capsules Players: Market Share by Revenue in Pomalidomide Capsules in 2023

Figure 20. Pomalidomide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Pomalidomide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Pomalidomide Capsules Sales Market Share by Country (2019-2030)

Figure 23. North America Pomalidomide Capsules Revenue Market Share by Country (2019-2030)

Figure 24. United States Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Pomalidomide Capsules Sales Market Share by Country (2019-2030)

Figure 27. Europe Pomalidomide Capsules Revenue Market Share by Country (2019-2030)

Figure 28. Germany Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Pomalidomide Capsules Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Pomalidomide Capsules Revenue Market Share by Region (2019-2030)

Figure 35. China Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Pomalidomide Capsules Sales Market Share by Country (2019-2030)

Figure 43. Mexico Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Pomalidomide Capsules Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Pomalidomide Capsules Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Pomalidomide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Pomalidomide Capsules by Type (2019-2030)

Figure 53. Global Revenue Market Share of Pomalidomide Capsules by Type (2019-2030)

Figure 54. Global Pomalidomide Capsules Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Pomalidomide Capsules by Application (2019-2030)

Figure 56. Global Revenue Market Share of Pomalidomide Capsules by Application (2019-2030)

Figure 57. Global Pomalidomide Capsules Price (US$/Unit) by Application (2019-2030)

Figure 58. Pomalidomide Capsules Value Chain

Figure 59. Pomalidomide Capsules Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions